Recent Study: Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014
Global Markets Direct's, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014', provides an overview of the Relapsing Multiple Sclerosis (RMS)'s therapeutic pipeline.
View full press release